TY - JOUR
T1 - Barriers of Acceptance to Hospice Care
T2 - a Randomized Vignette-Based Experiment
AU - Trandel, Elizabeth T.
AU - Lowers, Jane
AU - Bannon, Megan E.
AU - Moreines, Laura T.
AU - Dellon, Elisabeth P.
AU - White, Patrick
AU - Cross, Sarah H.
AU - Quest, Tammie E.
AU - Lagnese, Keith
AU - Krishnamurti, Tamar
AU - Arnold, Robert M.
AU - Harrison, Krista L.
AU - Patzer, Rachel E.
AU - Wang, Li
AU - Zarrabi, Ali John
AU - Kavalieratos, Dio
N1 - Funding Information:
During the conduct of this study, Dr. Kavalieratos received research support from the National Heart, Lung, and Blood Institute (K01HL133466). Drs. Trandel and Bannon both received internal funding from the University of Pittsburgh School of Medicine to conduct portions of this study.
Publisher Copyright:
© 2022, The Author(s) under exclusive licence to Society of General Internal Medicine.
PY - 2023/2
Y1 - 2023/2
N2 - Background: The per diem financial structure of hospice care may lead agencies to consider patient-level factors when weighing admissions. Objective: To investigate if treatment cost, disease complexity, and diagnosis are associated with hospice willingness to accept patients. Design: In this 2019 online survey study, individuals involved in hospice admissions decisions were randomized to view one of six hypothetical patient vignettes: “high-cost, high-complexity,” “low-cost, high-complexity,” and “low-cost, low-complexity” within two diseases: heart failure and cystic fibrosis. Vignettes included demographics, prognoses, goals, and medications with costs. Respondents indicated their perceived likelihood of acceptance to their hospice; if likelihood was <100%, respondents were asked the barriers to acceptance. We used bivariate tests to examine associations between demographic, clinical, and organizational factors and likelihood of acceptance. Participants: Individuals involved in hospice admissions decisions Main Measures: Likelihood of acceptance to hospice care Key Results: N=495 (76% female, 53% age 45–64). Likelihoods of acceptance in cystic fibrosis were 79.8% (high-cost, high-complexity), 92.4% (low-cost, high-complexity), and 91.5% (low-cost, low-complexity), and in heart failure were 65.9% (high-cost, high-complexity), 87.3% (low-cost, high-complexity), and 96.6% (low-cost, low-complexity). For both heart failure and cystic fibrosis, respondents were less likely to accept the high-cost, high-complexity patient than the low-cost, high-complexity patient (65.9% vs. 87.3%, 79.8% vs. 92.4%, both p<0.001). For heart failure, respondents were less likely to accept the low-cost, high-complexity patient than the low-cost, low-complexity patient (87.3% vs. 96.6%, p=0.004). Treatment cost was the most common barrier for 5 of 6 vignettes. Conclusions: This study suggests that patients receiving expensive and/or complex treatments for palliation may have difficulty accessing hospice.
AB - Background: The per diem financial structure of hospice care may lead agencies to consider patient-level factors when weighing admissions. Objective: To investigate if treatment cost, disease complexity, and diagnosis are associated with hospice willingness to accept patients. Design: In this 2019 online survey study, individuals involved in hospice admissions decisions were randomized to view one of six hypothetical patient vignettes: “high-cost, high-complexity,” “low-cost, high-complexity,” and “low-cost, low-complexity” within two diseases: heart failure and cystic fibrosis. Vignettes included demographics, prognoses, goals, and medications with costs. Respondents indicated their perceived likelihood of acceptance to their hospice; if likelihood was <100%, respondents were asked the barriers to acceptance. We used bivariate tests to examine associations between demographic, clinical, and organizational factors and likelihood of acceptance. Participants: Individuals involved in hospice admissions decisions Main Measures: Likelihood of acceptance to hospice care Key Results: N=495 (76% female, 53% age 45–64). Likelihoods of acceptance in cystic fibrosis were 79.8% (high-cost, high-complexity), 92.4% (low-cost, high-complexity), and 91.5% (low-cost, low-complexity), and in heart failure were 65.9% (high-cost, high-complexity), 87.3% (low-cost, high-complexity), and 96.6% (low-cost, low-complexity). For both heart failure and cystic fibrosis, respondents were less likely to accept the high-cost, high-complexity patient than the low-cost, high-complexity patient (65.9% vs. 87.3%, 79.8% vs. 92.4%, both p<0.001). For heart failure, respondents were less likely to accept the low-cost, high-complexity patient than the low-cost, low-complexity patient (87.3% vs. 96.6%, p=0.004). Treatment cost was the most common barrier for 5 of 6 vignettes. Conclusions: This study suggests that patients receiving expensive and/or complex treatments for palliation may have difficulty accessing hospice.
UR - http://www.scopus.com/inward/record.url?scp=85126899508&partnerID=8YFLogxK
U2 - 10.1007/s11606-022-07468-7
DO - 10.1007/s11606-022-07468-7
M3 - Article
C2 - 35319086
AN - SCOPUS:85126899508
SN - 0884-8734
VL - 38
SP - 277
EP - 284
JO - Journal of general internal medicine
JF - Journal of general internal medicine
IS - 2
ER -